Rare forms of genetic paediatric adrenal insufficiency: Excluding congenital adrenal hyperplasia

[1]  G. Raymond,et al.  Treatment of cerebral adrenoleukodystrophy: allogeneic transplantation and lentiviral gene therapy , 2022, Expert opinion on biological therapy.

[2]  H. Yoo.  Diverse etiologies, diagnostic approach, and management of primary adrenal insufficiency in pediatric age , 2021, Annals of pediatric endocrinology & metabolism.

[3]  A. Çayır,et al.  Catch-up growth and discontinuation of fludrocortisone treatment in aldosterone synthase deficiency. , 2021, The Journal of clinical endocrinology and metabolism.

[4]  T. Hanawa,et al.  Stability of Hydrocortisone in Oral Powder Form Compounded for Pediatric Patients in Japan , 2021, Pharmaceutics.

[5]  Yufei Shi,et al.  A Unique Genotype of Pseudohypoaldosteronism Type 1b in a Highly Consanguineous Population , 2021, Journal of the Endocrine Society.

[6]  M. Dattani,et al.  Genetic Analysis of Pediatric Primary Adrenal Insufficiency of Unknown Etiology: 25 Years’ Experience in the UK , 2021, Journal of the Endocrine Society.

[7]  P. White,et al.  Congenital adrenal hyperplasia - current insights in pathophysiology, diagnostics and management. , 2021, Endocrine reviews.

[8]  I. del Valle,et al.  Current Insights Into Adrenal Insufficiency in the Newborn and Young Infant , 2020, Frontiers in Pediatrics.

[9]  M. Maghnie,et al.  Primary Adrenal Insufficiency in childhood: data from a large nationwide cohort. , 2020, The Journal of clinical endocrinology and metabolism.

[10]  I. Banerjee,et al.  Hydrocortisone muco-adhesive buccal tablets continue to be used for the treatment of adrenal insufficiency in children in the UK , 2020, Archives of Disease in Childhood.

[11]  A. Efthymiadou,et al.  Molecular analysis of the CYP11B2 gene in 62 patients with Hypoaldosteronism due to Aldosterone Synthase Deficiency. , 2020, The Journal of clinical endocrinology and metabolism.

[12]  S. Wiegand,et al.  A Prospective Study of Children Aged 0–8 Years with CAH and Adrenal Insufficiency Treated with Hydrocortisone Granules , 2020, The Journal of clinical endocrinology and metabolism.

[13]  O. Ercan,et al.  Clinical and Genetic Characteristics of Patients with Corticosterone Methyloxidase Deficiency Type 2: Novel Mutations in CYP11B2 , 2020, Journal of clinical research in pediatric endocrinology.

[14]  P. Duminuco,et al.  Triple-A Syndrome (TAS): an in-depth overview on genetic and phenotype heterogeneity. , 2020, Protein and peptide letters.

[15]  David A. Williams,et al.  The Changing Face of Adrenoleukodystrophy. , 2020, Endocrine reviews.

[16]  G. Arnaldi,et al.  Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian Society of Endocrinology Expert Opinion , 2019, Journal of Endocrinological Investigation.

[17]  A. Moser,et al.  X-linked Adrenoleukodystrophy: Pathology, Pathophysiology, Diagnostic Testing, Newborn Screening, and Therapies , 2019, International Journal of Developmental Neuroscience.

[18]  R. Ferrigno,et al.  Abnormal linear growth in paediatric adrenal diseases: Pathogenesis, prevalence and management , 2019, Clinical endocrinology.

[19]  Ru-yuan Zhu,et al.  A novel SCNN1G mutation in a PHA I infant patient correlates with nephropathy. , 2019, Biochemical and biophysical research communications.

[20]  Kath Smith,et al.  Phenotypic diversity and correlation with the genotypes of pseudohypoaldosteronism type 1 , 2019, Journal of pediatric endocrinology & metabolism : JPEM.

[21]  L. Metherell,et al.  Isolated glucocorticoid deficiency: Genetic causes and animal models , 2019, The Journal of Steroid Biochemistry and Molecular Biology.

[22]  E. Sohara,et al.  Complete clinical resolution of a Japanese family with renal pseudohypoaldosteronism type 1 due to a novel NR3C2 mutation , 2019, Nephrology.

[23]  Sandra P. Spencer,et al.  Emergency management of adrenal insufficiency in children: advocating for treatment options in outpatient and field settings , 2019, Journal of Investigative Medicine.

[24]  C. Srichomthong,et al.  Identification and Functional Analysis of Six DAX1 Mutations in Patients With X-Linked Adrenal Hypoplasia Congenita , 2018, Journal of the Endocrine Society.

[25]  F. Faucz,et al.  SGPL1 Deficiency: A Rare Cause of Primary Adrenal Insufficiency. , 2018, The Journal of clinical endocrinology and metabolism.

[26]  Hongshan Chen,et al.  Etiology of primary adrenal insufficiency in children: a 29-year single-center experience , 2016, Journal of pediatric endocrinology & metabolism : JPEM.

[27]  Martin A. M. Reijns,et al.  DNA Polymerase Epsilon Deficiency Causes IMAGe Syndrome with Variable Immunodeficiency , 2018, American journal of human genetics.

[28]  J. Blair,et al.  The Challenges of Cortisol Replacement Therapy in Childhood: Observations from a Case Series of Children Treated with Modified-Release Hydrocortisone , 2018, Pediatric Drugs.

[29]  T. Novoselova,et al.  Pathophysiology of melanocortin receptors and their accessory proteins. , 2018, Best practice & research. Clinical endocrinology & metabolism.

[30]  R. Ross,et al.  Immediate-release granule formulation of hydrocortisone, Alkindi®, for treatment of paediatric adrenal insufficiency (Infacort development programme) , 2018, Expert review of endocrinology & metabolism.

[31]  M. Gershwin,et al.  The immunobiology and clinical features of type 1 autoimmune polyglandular syndrome (APS-1). , 2017, Autoimmunity reviews.

[32]  P. Knappskog,et al.  Expanding the Phenotypic and Genotypic Landscape of Autoimmune Polyendocrine Syndrome Type 1 , 2017, The Journal of clinical endocrinology and metabolism.

[33]  T. Tajima,et al.  Clinical features and molecular basis of pseudohypoaldosteronism type 1 , 2017, Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology.

[34]  A. Isidori,et al.  Baseline morning cortisol level as a predictor of pituitary–adrenal reserve: a comparison across three assays , 2017, Clinical endocrinology.

[35]  W. Miller.  Disorders in the initial steps of steroid hormone synthesis , 2017, The Journal of Steroid Biochemistry and Molecular Biology.

[36]  E. Husebye,et al.  AIRE-mutations and autoimmune disease. , 2016, Current opinion in immunology.

[37]  M. Cappa,et al.  Congenital primary adrenal insufficiency and selective aldosterone defects presenting as salt-wasting in infancy: a single center 10-year experience , 2016, Italian Journal of Pediatrics.

[38]  Ramona Jühlen,et al.  Identification of a novel putative interaction partner of the nucleoporin ALADIN , 2016, Biology Open.

[39]  Stefan R Bornstein,et al.  Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. , 2016, The Journal of clinical endocrinology and metabolism.

[40]  R. Sinke,et al.  A novel homozygous insertion and review of published mutations in the NNT gene causing familial glucocorticoid deficiency (FGD). , 2015, European journal of medical genetics.

[41]  L. Metherell,et al.  Whole-Exome Sequencing in the Differential Diagnosis of Primary Adrenal Insufficiency in Children , 2015, Front. Endocrinol..

[42]  A. Duncan,et al.  DAX-1 (NR0B1) and steroidogenic factor-1 (SF-1, NR5A1) in human disease , 2015, Best practice & research. Clinical endocrinology & metabolism.

[43]  W. Newman,et al.  Dominant Mutations in the Autoimmune Regulator AIRE Are Associated with Common Organ-Specific Autoimmune Diseases. , 2015, Immunity.

[44]  N. Krone,et al.  Current and novel approaches to children and young people with congenital adrenal hyperplasia and adrenal insufficiency. , 2015, Best practice & research. Clinical endocrinology & metabolism.

[45]  M. Dasouki,et al.  Phenotypic variation of autosomal recessive pseudohypoaldosteronism type I: a case in point , 2014, Clinical case reports.

[46]  L. Metherell,et al.  Thioredoxin Reductase 2 (TXNRD2) Mutation Associated With Familial Glucocorticoid Deficiency (FGD) , 2014, The Journal of clinical endocrinology and metabolism.

[47]  S. Hickey,et al.  Autosomal Dominant Pseudohypoaldosteronism Type 1 in an Infant with Salt Wasting Crisis Associated with Urinary Tract Infection and Obstructive Uropathy , 2013, Case reports in endocrinology.

[48]  M. Ridderstråle,et al.  Loss of Function of the Melanocortin 2 Receptor Accessory Protein 2 Is Associated with Mammalian Obesity , 2013, Science.

[49]  Claire Hughes,et al.  Familial glucocorticoid deficiency: New genes and mechanisms , 2013, Molecular and Cellular Endocrinology.

[50]  A. C. Santos,et al.  X-linked adrenoleukodystrophy in heterozygous female patients: women are not just carriers. , 2012, Arquivos de neuro-psiquiatria.

[51]  S. Nelson,et al.  Mutations in the PCNA-binding domain of CDKN1C cause IMAGE Syndrome , 2012, Nature Genetics.

[52]  P. Dahlqvist,et al.  Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation. , 2012, The Journal of clinical endocrinology and metabolism.

[53]  A. Say,et al.  Critical Points in the Management of Pseudohypoaldosteronism Type 1 , 2011, Journal of clinical research in pediatric endocrinology.

[54]  T. Jones,et al.  Structural chromosome disruption of the NR3C2 gene causing pseudohypoaldosteronism type 1 presenting in infancy , 2011, Journal of pediatric endocrinology & metabolism : JPEM.

[55]  H. Morita,et al.  Adult or late-onset triple A syndrome Case report and literature review , 2010, Journal of the Neurological Sciences.

[56]  L. Metherell,et al.  Phenotypic characteristics of familial glucocorticoid deficiency (FGD) type 1 and 2 , 2010, Clinical endocrinology.

[57]  A. Eliakim,et al.  Clinical and genetic heterogeneity of congenital adrenal hypoplasia due to NR0B1 gene mutations , 2010, Clinical endocrinology.

[58]  J. Saba,et al.  Sphingosine 1-phosphate lyase, a key regulator of sphingosine 1-phosphate signaling and function. , 2010, Advances in enzyme regulation.

[59]  J. Argente,et al.  [Primary hypoaldosteronism and moderate bilateral deafness in a child with a homozygous missense mutation (Thr318Met) in the CYP11B2 gene]. , 2010, Anales de pediatria.

[60]  H. Storr,et al.  Deficiency of ferritin heavy-chain nuclear import in triple a syndrome implies nuclear oxidative damage as the primary disease mechanism. , 2009, Molecular endocrinology.

[61]  D. Berney,et al.  Nonclassic lipoid congenital adrenal hyperplasia masquerading as familial glucocorticoid deficiency. , 2009, The Journal of clinical endocrinology and metabolism.

[62]  S. Moon,et al.  Tissue-specific expression and subcellular localization of ALADIN, the absence of which causes human triple A syndrome , 2009, Experimental & Molecular Medicine.

[63]  M. Elphick,et al.  MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family , 2009, Proceedings of the National Academy of Sciences.

[64]  P. Hindmarsh,et al.  A novel variant of familial glucocorticoid deficiency prevalent among the Irish Traveler population. , 2008, The Journal of clinical endocrinology and metabolism.

[65]  A. Holmgren,et al.  Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: implications for diseases in the cardiovascular system. , 2007, American journal of physiology. Heart and circulatory physiology.

[66]  W. Miller,et al.  Nonclassic congenital lipoid adrenal hyperplasia: a new disorder of the steroidogenic acute regulatory protein with very late presentation and normal male genitalia. , 2006, The Journal of clinical endocrinology and metabolism.

[67]  M. de Castro,et al.  Recurrence of the R947X mutation in unrelated families with autosomal dominant pseudohypoaldosteronism type 1: evidence for a mutational hot spot in the mineralocorticoid receptor gene. , 2006, The Journal of clinical endocrinology and metabolism.

[68]  J. Jameson,et al.  Analysis of DAX1 (NR0B1) and steroidogenic factor-1 (NR5A1) in children and adults with primary adrenal failure: ten years' experience. , 2006, The Journal of clinical endocrinology and metabolism.

[69]  M. Lei.  The MCM complex: its role in DNA replication and implications for cancer therapy. , 2005, Current cancer drug targets.

[70]  P. White.  Aldosterone synthase deficiency and related disorders , 2004, Molecular and Cellular Endocrinology.

[71]  L. Peltonen,et al.  AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype. , 2002, The Journal of clinical endocrinology and metabolism.

[72]  S. Hennig,et al.  Triple A syndrome is caused by mutations in AAAS, a new WD-repeat protein gene. , 2001, Human molecular genetics.

[73]  S. Rhee,et al.  Molecular Cloning and Characterization of a Mitochondrial Selenocysteine-containing Thioredoxin Reductase from Rat Liver* , 1999, The Journal of Biological Chemistry.

[74]  P. Donohoue,et al.  Clinical and functional effects of mutations in the DAX-1 gene in patients with adrenal hypoplasia congenita. , 1999, The Journal of clinical endocrinology and metabolism.

[75]  A. Clark,et al.  Adrenocorticotropin insensitivity syndromes. , 1998, Endocrine reviews.

[76]  W. Sippell,et al.  Congenital adrenal hypoplasia: clinical spectrum, experience with hormonal diagnosis, and report on new point mutations of the DAX-1 gene. , 1998, The Journal of clinical endocrinology and metabolism.

[77]  L. Peltonen,et al.  An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains , 1997, Nature Genetics.

[78]  Israel Hanukoglu,et al.  Routes and regulation of NADPH production in steroidogenic mitochondria. , 1995, Endocrine research.

[79]  A. Clark,et al.  Familial glucocorticoid deficiency associated with point mutation in the adrenocorticotropin receptor , 1993, The Lancet.

[80]  J. Zlotogora,et al.  Polyglandular autoimmune syndrome type I among Iranian Jews. , 1992, Journal of medical genetics.

[81]  N. Maclaren,et al.  Two Types of Autoimmune Addison's Disease Associated with Different Polyglandular Autoimmune (PGA) Syndromes , 1981, Medicine.

[82]  G. Clayden,et al.  FAMILIAL GLUCOCORTICOID DEFICIENCY WITH ACHALASIA OF THE CARDIA AND DEFICIENT TEAR PRODUCTION , 1978, The Lancet.